Figure 1.

Frequency of EGFR, ALK, ROS1, KRAS and BRAF mutations in NSCLC patients. Wild‐type of the five genes was 43.14%, concomitant mutations was 1.67% and EGFR/KRAS was the most frequent mutation type (0.53%). Other mutation types are also listed in the figure